Taking a pharmaceutical formulation of cannabidiol, a cannabis-based medicine, cut seizures nearly in half for children with a rare and severe type of epilepsy called Dravet syndrome, according to...

Albemarle Corporation (NYSE: ALB), a leader in the global specialty chemicals industry, announced today Luke Kissam, Albemarle CEO, Scott Tozier, Executive Vice President and Chief Financial...

Stealth BioTherapeutics (NASDAQ: MITO), a clinical-stage biotechnology company focused on the discovery, development and commercialization of novel therapies for diseases involving mitochondrial...

In celebration of its 25th anniversary as a leading developer, owner, builder, and manager of best-in-class multifamily housing, The NRP Group recently brought nearly 300 of its professionals to...

Hill-Rom Holdings, Inc. (NYSE: HRC), announced today that John Groetelaars, president and CEO, will present at the Bank of America Merrill Lynch 2019 Healthcare Conference on Tuesday, May 14,...